Extremely well-differentiated adenocarcinoma of the stomach: Clinicopathological and immunohistochemical features

Table 2 Clinicopathological data

Case	Age	Sex	Loc	Size	Macro	Depth	ly	v	LN	Prognosis	Biopsy
Gastric phenotype
1	81	m	M	5.5	0-I	sm	(+)	(-)	NA	5 mo, alive	benign
2	51	m	U	2.5	0-IIa	sm	(-)	(-)	(-)	23 mo, alive	NA
3	63	m	M	8	1	ss	(-)	(-)	(-)	66 mo, alive	benign
4	76	m	U	3.5	1	ss	(-)	(+)	(-)	30 mo, alive	Ca, susp
5	57	m	U	5	1	ss	(+)	(-)	(-)	48 mo, alive	NA
Intestinal phenotype (incomplete intestinal-type)
6	65	f	M	1.5	0-IIa	sm	(+)	(-)	(-)	38 mo, alive	Ca, susp
7	45	m	M	2.4	1	mp	(-)	(-)	(-)	129 mo, alive	Ca, susp
(complete intestinal-type)
8	54	m	M	2.2	0-IIc	sm	(-)	(-)	(-)	136 mo, alive	Ca, susp
9	65	m	M	4	1	mp	(+)	(+)	(-)	30 mo, alive	Ca, susp

Loc: location (U: upper third, M: middle third), Macro: macroscopic feature, Depth: depth of invasion (sm: submucosa, mp: muscularis propria, ss: subserosa), ly: lymphatic permeation, v: venous invasion, LN: lymph node metastasis, NA: not assessed, Ca, susp: carcinoma, suspected.